title: Polyamine regulation of plasma membrane phospholipid flip-flop during apoptosis.
abstract: During apoptosis, phosphatidylserine (PS) is moved from the plasma membrane inner leaflet to the outer leaflet where it triggers recognition and phagocytosis of the apoptotic cell. Although the mechanisms of PS appearance during apoptosis are not well understood, it is thought that declining activity of the aminophospholipid translocase and calcium-mediated, nonspecific flip-flop of phospholipids play a role. As previous studies in the erythrocyte ghost have shown that polyamines can alter flip-flop of phospholipids, we asked whether alterations in cellular polyamines in intact cells undergoing apoptosis would affect PS appearance, either by altering aminophospholipid translocase activity or phospholipid flip-flop. Cells of the human leukemic cell line, HL-60, were incubated with or without the ornithine decarboxylase inhibitor, difluoromethylornithine (DFMO), and induced to undergo apoptosis by ultraviolet irradiation. Whereas DFMO treatment resulted in profound depletion of putrescine and spermidine (but not spermine), it had no effect on caspase activity, DNA fragmentation, or plasma membrane vesiculation, typical characteristics of apoptosis. Notably, DFMO treatment prior to ultraviolet irradiation did not alter the decline in PS inward movement by the aminophospholipid translocase as measured by the uptake of 6-[(7-nitrobenz-2-oxa-1,3-diazol-4-yl)aminocaproyl] (NBD)-labeled PS detected in the flow cytometer. Conversely, the appearance of endogenous PS in the plasma membrane outer leaflet detected with fluorescein isothiocyanate-labeled annexin V and enhanced phospholipid flip-flop detected by the uptake of 1-palmitoyl-1-[6-[(7-nitro-2-1, 3-benzoxadiazol-4-yl)aminocaproyl]-sn-glycero-3-phosphocholine (NBD-PC) seen during apoptosis were significantly inhibited by prior DFMO treatment. Importantly, replenishment of spermidine, by treatment with exogenous putrescine to bypass the metabolic blockade by DFMO, restored both enhanced phospholipid flip-flop and appearance of PS during apoptosis. Such restoration was seen even in the presence of cycloheximide but was not seen when polyamines were added externally just prior to assay. Taken together, these data show that intracellular polyamines can modulate PS appearance resulting from nonspecific flip-flop of phospholipids across the plasma membrane during apoptosis.
authors.affiliation: National Jewish Medical and Research Center, Denver, Colorado 80206, USA. brattond@njc.org
authors.forename: D L
authors.initials: DL
authors.lastname: Bratton
authors.forename: V A
authors.initials: VA
authors.lastname: Fadok
authors.forename: D A
authors.initials: DA
authors.lastname: Richter
authors.forename: J M
authors.initials: JM
authors.lastname: Kailey
authors.forename: S C
authors.initials: SC
authors.lastname: Frasch
authors.forename: T
authors.initials: T
authors.lastname: Nakamura
authors.forename: P M
authors.initials: PM
authors.lastname: Henson
mesh_terms: D017209:Apoptosis / Q000502:physiology*; D001483:Base Sequence; D015317:Biogenic Polyamines / Q000378:metabolism / Q000502:physiology*; D017931:DNA Primers; D000518:Eflornithine / Q000494:pharmacology; D004791:Enzyme Inhibitors / Q000494:pharmacology; D018922:HL-60 Cells; D006801:Humans; D008563:Membrane Lipids / Q000378:metabolism*; D065108:Ornithine Decarboxylase Inhibitors; D010743:Phospholipids / Q000378:metabolism*
chemical_list: D015317:Biogenic Polyamines; D017931:DNA Primers; D004791:Enzyme Inhibitors; D008563:Membrane Lipids; D065108:Ornithine Decarboxylase Inhibitors; D010743:Phospholipids; D000518:Eflornithine